The demonstration of enrichment of response to NTRKi and other kinase inhibitors in the CRC subsets with high NTRK1/2/3 expression has certain implications for the potential predictive values of NTRK1/2/3 expression. Here, NTRK1 is linked to colorectal carcinoma.